Neurobiology of Aging
Volume 31, Issue 10 , Pages 1700-1709 , October 2010

Homocysteine and inflammation: Predictors of cognitive decline in older persons?

  • T.N. van den Kommer

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 204449337; fax: +31 204446775.
    • ,
  • M.G. Dik

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
    • Department of Nursing Home Medicine and EMGO Institute, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
    • ,
  • H.C. Comijs

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
    • Department of Psychiatry and EMGO Institute, VU University Medical Center, A.J. Ernststraat 887, 1081 HL Amsterdam, The Netherlands
    • ,
  • C. Jonker

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands
    • ,
  • D.J.H. Deeg

      Affiliations

    • Longitudinal Aging Study Amsterdam and EMGO Institute, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands

Received 18 April 2008 ,Revised 19 September 2008 ,Accepted 25 September 2008.

References 

  1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed.. Washington DC: American Psychiatric Association; 1994;
  2. Baron R, Harpaz I, Nemirovsky A, Cohen H, Monsonego A. Immunity and neuronal repair in the progression of Alzheimer's disease: a brief overview. Exp. Gerontol. 2007;42:64–69
  3. Bates CJ, Mansoor MA, van der Pols J, Prentice A, Cole TJ, Finch S. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur. J. Clin. Nutr. 1997;51:691–697
  4. Beekman ATF, Deeg DJH, van Limbeek J, Braam AW, de Vries MZ, van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol. Med. 1997;27:231–235
  5. Bremmer MA, Hoogendijk WJG, Deeg DJH, Schoevers RA, Schalk BWM, Beekman ATF. Depression in older age is a risk factor for first ischemic cardiac events. Am. J. Geriatr. Psychiatry. 2006;14:523–530
  6. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96:3542–3548
  7. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B-12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 1998;55:1449–1455
  8. Clarke R, Lewington S, Donald A, Johnston C, Refsum H, Stratton I, et al. Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J. Cardiovasc. Risk. 2001;8:363–369
  9. Deeg DJ, van Tilburg T, Smit JH, de Leeuw ED. Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. J. Clin. Epidemiol. 2002;55:319–328
  10. Dhonukshe-Rutten RAM, Pluijm SMF, de Groot LCPG, Lips P, Smit JH, van Staveren W. Homocysteine and vitamin B-12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J. Bone Miner. Res. 2005;20:921–929
  11. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005;64:1371–1377
  12. Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann. Neurol. 2003;53:214–221
  13. Durga J, van Tits LJ, Schouten EG, Kok FJ, Verhoef P. Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial. Arch. Intern. Med. 2005;165:1388–1394
  14. Elias MF, Sullivan LM, D’Agostino RB, Elias PK, Jacques PF, Selhub J, et al. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am. J. Epidemiol. 2005;162:644–653
  15. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol. 2004;61:668–672
  16. Feng L, Ng TP, Chuah L, Niti M, Kua EH. Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study. Am. J. Clin. Nutr. 2006;84:1506–1512
  17. Figueiras A, Domenech-Massons JM, Cadarso C. Regression models: calculating the confidence interval of effects in the presence of interactions. Stat. Med. 1998;17:2099–2105
  18. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  19. Friedewald WT, Levy RI, Frederickson DS. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  20. Garcia A, Haron Y, Pulman K, Hua L, Freedman M. Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. J. Gerontol. A: Biol. Sci. Med. Sci. 2004;59:1323–1327
  21. Gori AM, Corsi AM, Fedi S, Gazzini A, Sofi F, Bartali B, et al. A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am. J. Clin. Nutr. 2005;82:335–341
  22. Gori AM, Sofi F, Marcucci R, Giusti B, Gensini GF, Abbate R. Association between homocysteine, vitamin B6 concentrations and inflammation. Clin. Chem. Lab. Med. 2007;45:1728–1736
  23. Gunstad J, Bausserman L, Paul RH, Tate DF, Hoth K, Poppas A, et al. C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease.. J. Clin. Neurosci. 2006;13:540–546
  24. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 2007;85:511–517
  25. Havekes LM, de Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J. Lipid Res. 1987;28:455–463
  26. Jolles J, Verhey FRJ, Riedel WJ, Houx PJ. Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies. Drugs Aging. 1995;7:459–479
  27. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, et al. Homocysteine versus the vitamins folate, B-6, and B-12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur studies of successful aging. Am. J. Med. 2005;118:161–167
  28. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MMB. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol. 1999;150:283–289
  29. Kelly PJ, Kistler JP, Shih VE, Mandell R, Atassi N, Barron M, et al. Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke. 2004;35:12–15
  30. Klee GG. Cobalamin and folate evaluation: Measurement of methylmalonic acid and homocysteine vs. vitamin B(12) and folate. Clin. Chem. 2000;46:1277–1283
  31. Klerk M, Durga J, Schouten EG, Kluft C, Kok FJ, Verhoef P. No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults. Thromb. Haemost. 2005;94:96–100
  32. Kriegsman DMW, Penninx BWJH, van Eijk J, Boeke AJP, Deeg DJH. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients’ self-reports and on determinations of inaccuracy. J. Clin. Epidemiol. 1996;49:1407–1417
  33. Lazzerini PE, Capecchi PL, Selvi E, Lorenzini S, Bisogno S, Galeazzi M, et al. Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun. Rev. 2007;6:503–509
  34. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology. 2004;62:1972–1976
  35. McCaddon A, Hudson P, Davies G, Hughes A, Williams JHH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement. Geriatr. Cogn. Disord. 2001;12:309–313
  36. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–944
  37. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology. 2002;58:1471–1475
  38. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. Lancet. 1998;351:857–861
  39. Mooijaart SP, Gussekloo J, Frolich M, Jolles J, Stott DJ, Westendorp RGJ, et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study. Am. J. Clin. Nutr. 2005;82:866–871
  40. Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the cardiovascular health study cohort. J. Am. Geriatr. Soc. 2005;53:1101–1107
  41. Nilsson K, Hultberg B, Gustafson L. Lack of association between plasma homocysteine and inflammation in psychogeriatric patients. Dement. Geriatr. Cogn. Disord. 2002;14:151–155
  42. Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 2007;9:1941–1958
  43. Piccinin AM, Rabbitt PM. Contribution of cognitive abilities to performance and improvement on a substitution coding task. Psychol. Aging. 1999;14:539–551
  44. Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology. 2002;59:1375–1380
  45. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr. 2004;80:114–122
  46. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977;1:385–401
  47. Ravaglia G, Forti P, Maioli F, Zanardi V, Dalmonte E, Grossi G, et al. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J. Nutr. Health Aging. 2000;4:218–222
  48. Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am. J. Clin. Nutr. 2003;77:668–673
  49. Ravaglia G, Forti P, Maioli F, Servadei L, Martelli M, Arnone G, et al. Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. Exp. Gerontol. 2004;39:443–450
  50. Ravaglia G, Forti P, Maioli F, Montesi F, Rietti E, Pisacane N, et al. Risk factors for dementia: data from the Conselice Study of brain aging. Arch. Gerontol. Geriatr. 2007;44:311–320
  51. Ravaglia G, Forti P, Maioli F, Chiappelli M, Montesi F, Tumini E, et al. Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiol. Aging. 2007;28:1810–1820
  52. Raven JC. Manual for the Coloured Progressive Matrices (revised). Windsor, UK: NFER-Nelson; 1984;
  53. Reinhard O, Rood-Bakker D. Alcoholgebruik in beeld. Standaardmeetlat. Rotterdam: Nederlands Economisch Instituut; 1998;(in Dutch)
  54. Rey A. L’examen clinique en psychologie. Paris, France: Presses Universitaire de France; 1964;
  55. Rozemuller JM, Abbink JJ, Kamp AM, Stam FC, Hack CE, Eikelenboom P. Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. Acta Neuropathol. 1991;82:200–207
  56. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 1992;55:131–138
  57. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002;346:476–483
  58. Stel VS, Smit JH, Pluijm SMF, Visser M, Deeg DJH, Lips P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J. Clin. Epidemiol. 2004;57:252–258
  59. Teunissen CE, Blom AH, van Boxtel MP, Bosma H, de Bruijn C, Jolles J, et al. Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J. Nutr. Health Aging. 2003;7:153–159
  60. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am. J. Clin. Nutr. 2005;82:627–635
  61. Twisk JW, de Vente W. Roaming through methodology. XXII. Application of techniques for longitudinal data analysis. Ned. Tijdschr. Geneeskd. 2000;144:1680–1683
  62. Van den Heuvel N, Smits C. Intelligence: Raven's coloured progressive matrices. In:  Deeg DJ,  Westendorp-de Serière M editor. Autonomy and Well-Being in the Aging Population I: Report from the Longitudinal Aging Study Amsterdam 1992–1993. Amsterdam, The Netherlands: VU University Press; 1994;p. 53–58
  63. Van den Kommer, T.N., Comijs, H.C., Dik, M.G., Jonker, C., Deeg, D.J., 2008. Development of classification models for early identification of persons at risk for persistent cognitive decline. J. Neurol., doi:10.1007/s00415-008-0942-3.
  64. Van Oijen M, de Jong FJ, Witteman JCM, Hofman A, Koudstaal PJ, Breteler MMB. Atherosclerosis and risk for dementia. Ann. Neurol. 2007;61:403–410
  65. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003;61:76–80

PII: S0197-4580(08)00349-7

doi: 10.1016/j.neurobiolaging.2008.09.009

Neurobiology of Aging
Volume 31, Issue 10 , Pages 1700-1709 , October 2010

Article Tools

* Image Usage & Resolution